Search hospitals > Arizona > Tucson
Arizona Oncology Associates
Claim this profileTucson, Arizona 85704
Global Leader in Lung Cancer
Global Leader in Breast Cancer
Conducts research for Pancreatic Cancer
Conducts research for Cancer
Conducts research for Ovarian Cancer
75 reported clinical trials
5 medical researchers
Summary
Arizona Oncology Associates is a medical facility located in Tucson, Arizona. This center is recognized for care of Lung Cancer, Breast Cancer, Pancreatic Cancer, Cancer, Ovarian Cancer and other specialties. Arizona Oncology Associates is involved with conducting 75 clinical trials across 92 conditions. There are 5 research doctors associated with this hospital, such as Joseph Buscema, MD, Sudhir Manda, Suresh Mukkamala, MD, and Joesph Buscema, MD.Area of expertise
1Lung Cancer
Global LeaderStage IV
Stage III
HER2 negative
2Breast Cancer
Global LeaderStage IV
HER2 negative
ER positive
Top PIs
Joseph Buscema, MDArizona Oncology Associates5 years of reported clinical research
Expert in Ovarian Cancer
Studies Fallopian Tube Cancer
19 reported clinical trials
33 drugs studied
Sudhir MandaArizona Oncology Associates5 years of reported clinical research
Studies Lymphoma
Studies Colorectal Cancer
17 reported clinical trials
40 drugs studied
Suresh Mukkamala, MDArizona Oncology Associates7 years of reported clinical research
Studies Colorectal Cancer
Studies Pancreatic Cancer
2 reported clinical trials
4 drugs studied
Joesph Buscema, MDArizona Oncology9 years of reported clinical research
Studies Lung Cancer
Studies Cancer
1 reported clinical trial
6 drugs studied
Clinical Trials running at Arizona Oncology Associates
Breast Cancer
Ovarian Cancer
Melanoma
Multiple Myeloma
Cancer
Cytokine Release Syndrome
Bladder Cancer
Renal Cell Carcinoma
Colorectal Cancer
Lung Cancer
PCS6422 + Capecitabine
for Breast Cancer
This is an adaptive Phase 2, open-label, randomized, multi-center study evaluating up to 2 regimens of PCS6422 with capecitabine (Cap) vs. standard dose of Cap alone in patients with advanced or metastatic breast cancer. The goal of the study is to assess the efficacy and safety of PCS6422 + Cap as a treatment option for patients with advanced or metastatic breast cancer who are not eligible for anthracycline- or taxane-containing therapies, or other available therapies, including PD-1 or PARP inhibitors.
Recruiting1 award Phase 24 criteria
TTX-080 +/− Cetuximab/Pembrolizumab
for Cancer
This trial tests TTX-080, a new drug, alone and with other cancer drugs in patients with hard-to-treat cancers. It works by helping the immune system find and attack cancer cells.
Recruiting1 award Phase 14 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Arizona Oncology Associates?
Arizona Oncology Associates is a medical facility located in Tucson, Arizona. This center is recognized for care of Lung Cancer, Breast Cancer, Pancreatic Cancer, Cancer, Ovarian Cancer and other specialties. Arizona Oncology Associates is involved with conducting 75 clinical trials across 92 conditions. There are 5 research doctors associated with this hospital, such as Joseph Buscema, MD, Sudhir Manda, Suresh Mukkamala, MD, and Joesph Buscema, MD.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.